NewsRoom Articles - Page 1207 of 1389

WednesdayJul 26, 2017 11:49 am

American Energy Partners, Inc. (XFUL) – Who Says Oil and Water Don’t Mix?

Fracking now accounts for half of oil production, and 90 percent of new wells are fracked Water remains a limited resource, yet is vital to fracking process American Energy Partners' vertically-integrated subsidiaries deliver solutions No matter what the future may hold, for now, the world runs on oil. Oil is the life blood of the world’s economic development, and obtaining oil has been an ongoing quest since long before the invention of the internal combustion engine. The first successful oil well in the U.S. was drilled near Titusville, Pennsylvania, in 1859. From there, drilling moved rapidly across the entire country,…

WednesdayJul 26, 2017 9:00 am

Investment Options in the Multi-Billion Dollar Medical Marijuana Industry

NetworkNewsWire Editorial Coverage: Mounting research from around the world suggests marijuana’s potential to treat multiple medical conditions ranging from chronic pain to cancer, epilepsy, HIV/AIDS, anxiety and more. Predicted to reach $55.8 billion by 2025(1), the global medical marijuana industry presents to investors a wide array of investment opportunities, driven by increasing demand for therapeutic applications of the drug. In turn, funds raised through the public market give marijuana companies the chance to raise capital to build stronger portfolios, increase their market reach and revenue, and offer cannabis-based alternatives to traditional medicine. Companies such as ChineseInvestors.com, Inc. (CIIX) (Profile: CIIX),…

TuesdayJul 25, 2017 3:47 pm

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Patented Cannabinoid Delivery System Approved

Patented lipophilic delivery system increases bio-absorption Patents cover broad range of lipophilic bio-actives, including cannabinoids, vitamins, other pharma 19 patents filed across 44 countries First international patent issued and approved in Australia Any argument over the efficacy of medicinal marijuana is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://nnw.fm/7HnBi). However, the human gastrointestinal tract just doesn’t absorb cannabinoids effectively, and much of what is ingested is simply excreted by the body. Subsequently, onset times and effectiveness vary wildly. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB:…

TuesdayJul 25, 2017 1:22 pm

SinglePoint (SING) Sees Advantages in Bitcoin, Formation of SingleSeed.com, and Joint Venture with First Bitcoin Capital Corp.

Company sees four to five more acquisitions in pipeline after its investment in California firms DIGS and Convectium Hired a blockchain expert as part of project addressing payment processes for the cannabis industry Hired Turner, Stone & Company LLC to complete 2016 financial audit Wil Ralston, president of SinglePoint, Inc., (OTC: SING), and Greg Lambrecht, CEO, say their company is primed to make four to five more acquisitions as it sees further opportunity in the cannabis market and medical marijuana. It is supporting dispensaries with the cryptocurrency bitcoin and is helping legal sellers solidify an online presence with subsidiary SingleSeed.com.…

TuesdayJul 25, 2017 12:30 pm

Moxian, Inc. (NASDAQ: MOXC) Taking Aim at a Spectacular Trend that’s Transforming the World’s Second-Largest Economy

China’s economy is the world’s second-largest Former chairman of Morgan Stanley Asia says China is on the cusp of an incredible growth spurt Moxian contributes to and reaps rewards from China’s growth China, the world’s second-largest economy, is on the cusp of an incredible growth spurt, says Stephen Roach, the former chairman of Morgan Stanley Asia (http://nnw.fm/eYSo7). In a recent CNBC interview, Roach stated, "The Chinese economy seems to be making remarkable progress in transforming itself into more of a consumer-based model... The wave of innovation in their private-based economy, anything from e-commerce to medical sciences, is really quite spectacular...…

TuesdayJul 25, 2017 9:00 am

Potential Blockbuster Treatment for Alzheimer’s Disease Stands Out Among Medical Cannabis Companies

NetworkNewsWire Editorial Coverage: Changes in public opinion regarding cannabis have greatly fueled the fire blazing under the red-hot state-legalized marijuana market. A recent Gallup poll shows that 60 percent of Americans now support the legalization of marijuana1, while another report shows that marijuana sales jumped an incredible 30 percent in North America in 2016 to reach $6.7 billion2. While many investors are looking to find profitable plays in this burgeoning market, continuing federal restrictions make medical marijuana one of the safest investment routes. Standout companies that present prime opportunities in this space include India Globalization Capital, Inc. (NYSE MKT: IGC)…

MondayJul 24, 2017 3:33 pm

Global Payout, Inc. (GOHE) is Making Worldwide Financial Transactions Seamless

Connecting a global financial market to a private banking network A cloud-based financial platform for trading & settlement of depositary accounts Using blockchain technology to deliver secure financial transactions Banking has come a long way from the time when moneychangers set up their tables in the marketplace. The technology then was minimal: paper records of bills of exchange and letters of credit. Today, technology dominates banking. More than a quarter (about 9,000) of Goldman Sachs’ 33,000 full-time employees are engineers and programmers, by one account (http://nnw.fm/9apGZ). Its CEO is on record as saying that Goldman Sachs (NYSE: GS) is a…

MondayJul 24, 2017 1:52 pm

MoneyOnMobile (MOMT) Digital Mobile Payment Network Services World’s Largest Under-Banked Population

India has world’s second-largest population at 1.35 billion India is largest under-banked population in the world MoneyOnMobile services under-banked with digital mobile payment network 39 percent monthly compounded revenue growth in Q1 With an average growth rate of around seven percent over the last two decades, India’s economy is the sixth-largest in the world measured by GDP and the third-largest by purchasing power. In spite of its economic prowess, the Indian consumer market is the largest under-banked population in the world. Banking services are scarce and woefully inadequate, forcing cash transactions and chocking consumer purchasing power. A prime example of…

MondayJul 24, 2017 12:32 pm

Impressive Growth Trajectory Continues for Net Element (NASDAQ: NETE)

Proven player in the payments-as-a-service market Company’s business growth increased by 40% in 2017’s first quarter Projected to reach $75 million in revenues by 2018 Exciting developments continue for Net Element, Inc. (NASDAQ: NETE), which has become a proven entity within the thriving payments-as-a-service market. Net Element is a global financial technology and value-added solutions group engaged in supporting electronic payments acceptance in an omni-channel environment that spans point-of-sale, e-commerce and mobile devices. The company’s payments-as-a-service transactional and value-added services platform caters to small-to-medium enterprises (SME) in the United States and in selected emerging markets. Net Element was hailed as…

MondayJul 24, 2017 12:06 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Aims at Future of Cannabinoid Compound Treatment

Specializing in novel cannabinoid drug therapies, InMed Pharmaceuticals is well-poised for cannabinoid research and development of new treatments Glaucoma and skin disease pharmaceuticals now in development have an estimated $7.6 billion potential market InMed Pharmaceutical’s chief medical officer helped $3 billion GW Pharmaceuticals develop one of the first cannabis-based drugs With its proprietary bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is well-positioned to target the future of cannabinoid pharmaceutical compounds. InMed is a pre-clinical stage biopharmaceutical company specializing in the development of novel therapies through research and development of the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000